PureTech Health (PRTC) RNS Announcements

Add to Alert list
Date Time Source Announcement
03 Jun 2019 07:00 AM
RNS
PRTC's Karuna Files Public S1 for NASDAQ IPO
30 May 2019 07:05 AM
RNS
PRTC to Present at Jefferies US Conference
30 May 2019 07:00 AM
RNS
Result of AGM
29 May 2019 07:00 AM
RNS
Vor Publishes POC Study in Scientific Journal
21 May 2019 07:00 AM
RNS
Vedanta Presents Expanded Data from Successful Ph1
20 May 2019 07:00 AM
RNS
Promising Gelesis Data in Chronic Constipation
14 May 2019 07:00 AM
RNS
Gelesis & Vedanta Data at Digestive Disease Week
13 May 2019 07:00 AM
RNS
Vedanta Grows Series C Financing to $45.5 Million
07 May 2019 07:00 AM
RNS
Vedanta Prevails in Important EU Patent Opposition
26 Apr 2019 07:15 AM
RNS
PRTC's Karuna Files IPO Registration Statement
25 Apr 2019 07:00 AM
RNS
Gelesis Gets $10.6M Grant to Support Manufacturing
24 Apr 2019 07:00 AM
RNS
Final Results
17 Apr 2019 07:00 AM
RNS
Boehringer Ingelheim & PRTC Immuno-oncology Collab
15 Apr 2019 07:00 AM
RNS
Gelesis Receives FDA Clearance for First Product
11 Apr 2019 01:00 PM
RNS
Akili Makes CFO & General Counsel Appointments
11 Apr 2019 07:05 AM
RNS
Gelesis Presents Data on Effects of High-Fat Diet
11 Apr 2019 07:00 AM
RNS
Sonde Completes $16M Series A Financing Round
02 Apr 2019 07:00 AM
RNS
PRTC Presents Immuno-Oncology Programmes at AACR
01 Apr 2019 12:05 PM
RNS
Karuna expands Series B financing to $80 million
25 Mar 2019 06:00 PM
RNS
Gelesis New Clinical Data on Impact of Gelesis100
25 Mar 2019 06:00 PM
RNS
Gelesis Preclinical Data on Restoring Gut Barrier
21 Mar 2019 07:00 AM
RNS
Gelesis to Present at Endocrine Society Annual Mtg
18 Mar 2019 07:00 AM
RNS
Karuna Announces $68 Million Series B Financing
15 Mar 2019 07:00 AM
RNS
Notice of Results
07 Mar 2019 07:00 AM
RNS
Akili & Shionogi Deal in Taiwan/Japan $20M upfront
05 Mar 2019 07:00 AM
RNS
Karuna Appoints Chief Financial Officer
22 Feb 2019 04:41 PM
RNS
Second Price Monitoring Extn
22 Feb 2019 04:36 PM
RNS
Price Monitoring Extension
21 Feb 2019 07:00 AM
RNS
PRTC to Present at Two US Investor Conferences
15 Feb 2019 04:41 PM
RNS
Second Price Monitoring Extn
15 Feb 2019 04:35 PM
RNS
Price Monitoring Extension
14 Feb 2019 07:00 AM
RNS
Vor Raises $42M to Advance Leukaemia Treatment
28 Jan 2019 07:00 AM
RNS
Alivio Partners to Advance Non-opioid Pain Therapy
23 Jan 2019 06:08 PM
RNS
Vedanta Immuno-oncology Candidate Published
02 Jan 2019 07:00 AM
RNS
Total Voting Rights
28 Dec 2018 12:07 PM
RNS
Second Price Monitoring Extn
28 Dec 2018 12:02 PM
RNS
Price Monitoring Extension
24 Dec 2018 07:00 AM
RNS
Vedanta Biosciences Raise $27M Series C Financing
17 Dec 2018 07:00 AM
RNS
Vedanta Initiates Phase 2 Study for Lead Candidate
10 Dec 2018 07:00 AM
RNS
Vedanta & BMS Immuno-Oncology Collaboration
28 Nov 2018 07:00 AM
RNS
Vor Granted First-in-class Immuno-oncology Patent
27 Nov 2018 07:00 AM
RNS
Janssen/Vedanta Phase 1 in IBD & $12M Milestone
26 Nov 2018 04:40 PM
RNS
Second Price Monitoring Extn
26 Nov 2018 04:35 PM
RNS
Price Monitoring Extension
22 Nov 2018 12:07 PM
RNS
Second Price Monitoring Extn
22 Nov 2018 12:02 PM
RNS
Price Monitoring Extension
16 Nov 2018 12:07 PM
RNS
Second Price Monitoring Extn
16 Nov 2018 12:02 PM
RNS
Price Monitoring Extension
14 Nov 2018 12:07 PM
RNS
Second Price Monitoring Extn
14 Nov 2018 12:02 PM
RNS
Price Monitoring Extension

PureTech Health is a biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange under the ticker PRTC.

PureTech share price launched at 178p in 2015.

UK 100

Latest directors dealings